Skip to main content

ORIGINAL RESEARCH article

Front. Pharmacol., 27 November 2020
Sec. Drugs Outcomes Research and Policies
Volume 11 - 2020 | https://doi.org/10.3389/fphar.2020.614290

Updated

A correction has been applied to this article in:

  1. Corrigendum: Formulation and development of transferrin targeted solid lipid nanoparticles for breast cancer therapy

    1. Read correction

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.